Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
M414120-5mg
|
5mg |
2
|
$187.90
|
|
|
M414120-10mg
|
10mg |
2
|
$274.90
|
|
|
M414120-25mg
|
25mg |
2
|
$432.90
|
|
|
M414120-50mg
|
50mg |
1
|
$590.90
|
|
E1 Activating Inhibitors
| Synonyms | Sulfamic acid,[(1R,2S,4R)-4-[[5-[[1-[(3-bromophenyl)methyl]-1H-pyrazol-3-yl]carbonyl]-4-pyrimidinyl]amino]-2-hydroxycyclopentyl]methyl ester |
|---|---|
| Specifications & Purity | ≥99% |
| Biochemical and Physiological Mechanisms | ML-792 is a potent and selective inhibitor of SUMO (small ubiquitin-like modifier)-activating enzyme (SAE). ML-792 inhibits SAE/SUMO1 and SAE/SUMO2 in ATP–inorganic pyrophosphate (PPi) exchange assays with IC50 of 3 nM and 11 nM, respectively. |
| Storage Temp | Store at -20°C,Argon charged |
| Shipped In |
Ice chest + Ice pads This product requires cold chain shipping. Ground and other economy services are not available. |
| Product Description |
SAE/SUMO1 (Cell-free assay); SAE/SUMO2 (Cell-free assay) 3 nM; 11 nM In vitro ML-792 is a mechanism-based SUMO-activating enzyme (SAE) inhibitor with nanomolar potency in cellular assays. ML-792 selectively blocks SAE enzyme activity and total SUMOylation, thus decreasing cancer cell proliferation. Induction of the MYC oncogene increases the ML-792-mediated viability effect in cancer cells, thus indicating a potential application of SAE inhibitors in treating MYC-amplified tumors. Cell Research(from reference) Cell lines:HCT116 cells Concentrations:0.5 μM Incubation Time:48 h |
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organoheterocyclic compounds |
| Class | Diazines |
| Subclass | Pyrimidines and pyrimidine derivatives |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Pyrimidinecarboxylic acids and derivatives |
| Alternative Parents | Aryl ketones Secondary alkylarylamines Bromobenzenes Imidolactams Cyclopentanols Alpha-branched alpha,beta-unsaturated ketones Vinylogous amides Organic sulfuric acids and derivatives Heteroaromatic compounds Enones Azoles Acryloyl compounds Cyclic alcohols and derivatives Vinyl bromides Propargyl-type 1,3-dipolar organic compounds Hydrazones Carboximidamides Bromoalkenes Azacyclic compounds Amidines Organopnictogen compounds Organobromides Organic oxides Hydrocarbon derivatives |
| Molecular Framework | Aromatic heteromonocyclic compounds |
| Substituents | Pyrimidine-5-carboxylic acid or derivatives - Aryl ketone - Secondary aliphatic/aromatic amine - Halobenzene - Bromobenzene - Imidolactam - Alpha-branched alpha,beta-unsaturated-ketone - Benzenoid - Cyclopentanol - Monocyclic benzene moiety - Heteroaromatic compound - Vinylogous amide - Alpha,beta-unsaturated ketone - Organic sulfuric acid or derivatives - Enone - Cyclic alcohol - Azole - Acryloyl-group - Secondary alcohol - Ketone - Azacycle - Bromoalkene - Haloalkene - Organic 1,3-dipolar compound - Propargyl-type 1,3-dipolar organic compound - Carboximidamide - Vinyl halide - Vinyl bromide - Secondary amine - Hydrazone - Amidine - Organic nitrogen compound - Organic oxygen compound - Organopnictogen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Organonitrogen compound - Organobromide - Organohalogen compound - Amine - Alcohol - Aromatic heteromonocyclic compound |
| Description | This compound belongs to the class of organic compounds known as pyrimidinecarboxylic acids and derivatives. These are compounds containing a pyrimidine ring which bears a carboxylic acid group (or a derivative thereof). |
| External Descriptors | Not available |
|
|
|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| IUPAC Name | [(1R,2S,4R)-4-[[5-[1-[(3-bromophenyl)methyl]pyrazole-3-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate |
|---|---|
| INCHI | InChI=1S/C21H23BrN6O5S/c22-15-3-1-2-13(6-15)10-28-5-4-18(27-28)20(30)17-9-24-12-25-21(17)26-16-7-14(19(29)8-16)11-33-34(23,31)32/h1-6,9,12,14,16,19,29H,7-8,10-11H2,(H2,23,31,32)(H,24,25,26)/t14-,16-,19+/m1/s1 |
| InChIKey | PZCKLTWSXFDLLP-OGWOLHLISA-N |
| Smiles | C1C(CC(C1COS(=O)(=O)N)O)NC2=NC=NC=C2C(=O)C3=NN(C=C3)CC4=CC(=CC=C4)Br |
| Isomeric SMILES | C1[C@H](C[C@@H]([C@H]1COS(=O)(=O)N)O)NC2=NC=NC=C2C(=O)C3=NN(C=C3)CC4=CC(=CC=C4)Br |
| PubChem CID | 86566743 |
| Molecular Weight | 551.41 |
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Sep 12, 2024 | M414120 | |
| Certificate of Analysis | Sep 12, 2024 | M414120 | |
| Certificate of Analysis | Sep 12, 2024 | M414120 | |
| Certificate of Analysis | Sep 12, 2024 | M414120 | |
| Certificate of Analysis | Sep 12, 2024 | M414120 | |
| Certificate of Analysis | Sep 12, 2024 | M414120 | |
| Certificate of Analysis | Sep 12, 2024 | M414120 | |
| Certificate of Analysis | Sep 12, 2024 | M414120 |
| Solubility | Solubility (25°C) In vitro DMSO: 100 mg/mL (181.35 mM); Water: Insoluble; Ethanol: Insoluble; |
|---|---|
| Molecular Weight | 551.400 g/mol |
| XLogP3 | 2.300 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 9 |
| Exact Mass | 550.063 Da |
| Monoisotopic Mass | 550.063 Da |
| Topological Polar Surface Area | 171.000 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 801.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |